SEC Tracker
Get the app

Anavex Life Sciences AVXL

Anavex Life Sciences sees director departures

Item 5.02 Executive or director change, Item 8.01 Other events

Form
8-K
Filed
Importance
Major
  1. Dr. Jiong Ma, Mr. Gautam Patel, and Dr. Adrian Senderowicz resigned from the Board on October 28, 2026.
  2. Dr. Ma was Chair of the Board and a member of the Audit Committee.
  3. The Board reconstituted its committees on November 1, 2026.
  4. Resignation letters are filed as exhibits 17.1, 17.2, and 17.3.

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Anavex Life Sciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. ImmunityBio IBRX public float $690M, Jun 30, 2025
  2. Immunome IMNM public float $729M, Jun 30, 2025
  3. Pacira BioSciences PCRX public float $758M, Jun 30, 2025
  4. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  5. uniQure QURE public float $765M, Jun 30, 2025